142 related articles for article (PubMed ID: 23051823)
1. British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate.
Bicanic T; Ogden D; Whitney L; Loyse A; Jarvis J
HIV Med; 2012 Nov; 13(10):636-7. PubMed ID: 23051823
[No Abstract] [Full Text] [Related]
2. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
[TBL] [Abstract][Full Text] [Related]
3. Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial.
Techapornroong M; Suankratay C
Scand J Infect Dis; 2007; 39(10):896-901. PubMed ID: 17852947
[TBL] [Abstract][Full Text] [Related]
4. Antifungal treatment for cryptococcal meningitis.
Powderly WG
Intern Med J; 2006 Jul; 36(7):404-5. PubMed ID: 16780444
[No Abstract] [Full Text] [Related]
5. Editorial commentary: dosing amphotericin B in cryptococcal meningitis.
Powderly WG
Clin Infect Dis; 2008 Jul; 47(1):131-2. PubMed ID: 18505386
[No Abstract] [Full Text] [Related]
6. Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity.
Falci DR; Lunardi LW; Ramos CG; Bay MB; Aquino VR; Goldani LZ
Clin Infect Dis; 2010 Mar; 50(5):e26-9. PubMed ID: 20121575
[TBL] [Abstract][Full Text] [Related]
7. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review.
Macsween KF; Bicanic T; Brouwer AE; Marsh H; Macallan DC; Harrison TS
J Infect; 2005 Nov; 51(4):e221-4. PubMed ID: 16291274
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis.
Joly V; Aubry P; Ndayiragide A; Carrière I; Kawa E; Mlika-Cabanne N; Aboulker JP; Coulaud JP; Larouze B; Yeni P
Clin Infect Dis; 1996 Sep; 23(3):556-62. PubMed ID: 8879780
[TBL] [Abstract][Full Text] [Related]
9. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation.
Mohr JF; Hall AC; Ericsson CD; Ostrosky-Zeichner L
Pharmacotherapy; 2005 Mar; 25(3):426-8. PubMed ID: 15843289
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment with amphotericin B plus rifampin in the acute treatment of cryptococcal meningitis in aids.
Chotmongkol V; Methawasin K
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):776-8. PubMed ID: 12041553
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis.
Chen CH; Li H; Chen HM; Chen YM; Chang YJ; Lin PY; Hsu CW; Tseng PT; Lin KH; Tu YK
Sci Rep; 2021 Apr; 11(1):8565. PubMed ID: 33883566
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal meningitis.
Ming DK; Harrison TS
Br J Hosp Med (Lond); 2017 Aug; 78(8):C125-C127. PubMed ID: 28783390
[No Abstract] [Full Text] [Related]
14. Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
Warrell CE; Macrae C; McLean ARD; Wilkins E; Ashley EA; Smithuis F; Tun NN
BMC Infect Dis; 2021 Apr; 21(1):375. PubMed ID: 33882845
[TBL] [Abstract][Full Text] [Related]
15. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study.
Ahimbisibwe C; Kwizera R; Ndyetukira JF; Kugonza F; Sadiq A; Hullsiek KH; Williams DA; Rhein J; Boulware DR; Meya DB
BMC Infect Dis; 2019 Jun; 19(1):558. PubMed ID: 31242860
[TBL] [Abstract][Full Text] [Related]
16. Free fluconazole for cryptococcal meningitis: too little of a good thing?
Hamill RJ
Clin Infect Dis; 2006 Oct; 43(8):1074-6. PubMed ID: 16983623
[No Abstract] [Full Text] [Related]
17. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
18. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
Sharkey PK; Graybill JR; Johnson ES; Hausrath SG; Pollard RB; Kolokathis A; Mildvan D; Fan-Havard P; Eng RH; Patterson TF; Pottage JC; Simberkoff MS; Wolf J; Meyer RD; Gupta R; Lee LW; Gordon DS
Clin Infect Dis; 1996 Feb; 22(2):315-21. PubMed ID: 8838189
[TBL] [Abstract][Full Text] [Related]
19. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
20. Elution of High Dose Amphotericin B Deoxycholate From Polymethylmethacrylate.
Houdek MT; Greenwood-Quaintance KE; Morrey ME; Patel R; Hanssen AD
J Arthroplasty; 2015 Dec; 30(12):2308-10. PubMed ID: 26162513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
